78 related articles for article (PubMed ID: 2980304)
1. Pharmacokinetics of iopentol in healthy volunteers.
Waaler A; Jørgensen NP; Koksvik B; Skinnemoen K; Andrew E
Acta Radiol Suppl; 1987; 370():113-7. PubMed ID: 2980304
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic effects of iopentol after intravenous injection in healthy volunteers. Preliminary report.
Aakhus T; Stokke O; Stormorken H; Berg KJ; Dahlstrøm K
Acta Radiol Suppl; 1987; 370():109-12. PubMed ID: 2980303
[TBL] [Abstract][Full Text] [Related]
3. Renal effects of the non-ionic contrast medium iopentol after intravenous injection in healthy volunteers.
Jakobsen JA; Berg KJ; Waaler A; Andrew E
Acta Radiol; 1990 Jan; 31(1):87-91. PubMed ID: 2187515
[TBL] [Abstract][Full Text] [Related]
4. Human pharmacokinetics of iodixanol.
Svaland MG; Haider T; Langseth-Manrique K; Andrew E; Hals PA
Invest Radiol; 1992 Feb; 27(2):130-3. PubMed ID: 1601604
[TBL] [Abstract][Full Text] [Related]
5. Safety and toleration of the non-ionic contrast medium iopentol. An intravenous phase I trial.
Jakobsen JA; Hagve TA; Holager T; Waaler A; Haider T; Andrew E; Aakhus T
Eur J Radiol; 1989 Nov; 9(4):203-7. PubMed ID: 2591384
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of iopentol in the rat.
Michelet AA; Skinnemoen K
Acta Radiol Suppl; 1987; 370():101-4. PubMed ID: 2980301
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of iopentol in patients with chronic renal failure.
Svaland MG; Kolmannskog F; Lillevold PE; Nordal KP; Ressem L; Berg KJ
Acta Radiol; 1992 Sep; 33(5):482-4. PubMed ID: 1389660
[TBL] [Abstract][Full Text] [Related]
8. Metabolism and excretion of iopentol in the pig.
Leunbach I; Skinnemoen K; Golman K
Acta Radiol Suppl; 1987; 370():105-7. PubMed ID: 2980302
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of iotrolan after intravenous injection into healthy volunteers.
Scholz P; Weinmann HJ; Mützel W; Staks T
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():211-4. PubMed ID: 2568798
[TBL] [Abstract][Full Text] [Related]
10. Renal effects of iopentol and iohexol after intravenous injection.
Jakobsen JA; Kolbenstvedt AN; Berg KJ
Acta Radiol; 1991 Jul; 32(4):320-4. PubMed ID: 1863505
[TBL] [Abstract][Full Text] [Related]
11. Iopentol in patients with chronic renal failure: its effects on renal function and its use as glomerular filtration rate parameter.
Berg KJ; Kolmannskog F; Lillevold PE; Nordal KP; Ressem L; Rootwelt K; Svaland MG
Scand J Clin Lab Invest; 1992 Feb; 52(1):27-33. PubMed ID: 1594886
[TBL] [Abstract][Full Text] [Related]
12. Systemic, pulmonary and renal haemodynamic effects of intravenously infused iopentol. A comparison in the pig of a new low osmolar non-ionic medium with saline and iohexol.
Sunnegårdh O; Hietala SO; Wirell S; Ekelund L
Acta Radiol; 1990 Jul; 31(4):395-9. PubMed ID: 2206697
[TBL] [Abstract][Full Text] [Related]
13. Clinical trial program for iopentol. A new nonionic ratio 3.0 contrast medium with emphasis on clinical phases I and II.
Andrew E; Waaler A; Jakobsen J; Holager T; Lambrechts M; Moxnes A; Kruger Hagen E; Bach-Gansmo T
Invest Radiol; 1988 Sep; 23 Suppl 1():S189-92. PubMed ID: 3058629
[TBL] [Abstract][Full Text] [Related]
14. Reducing the risk of ventricular fibrillation by adding sodium to ionic and non-ionic contrast media with low iodine concentration. Coronary perfusion of the isolated rabbit heart with meglumine diatrizoate or iopentol at 140 mg I/ml and 0-154 mmol Na+/l.
Bååth L; Almén T
Acta Radiol; 1989; 30(2):207-12. PubMed ID: 2647114
[TBL] [Abstract][Full Text] [Related]
15. Tissue distribution and excretion of iotrolan after intravenous and suboccipital injections in animals.
Weinmann HJ; Scholz P; Mützel W
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():206-10. PubMed ID: 2568796
[TBL] [Abstract][Full Text] [Related]
16. Nonionic contrast media in pediatric CT. A comparative study of intravenous use of iopentol and iohexol.
Wiklund LM; Brolin I; Sjöholm K
Acta Radiol; 1994 Mar; 35(2):186-90. PubMed ID: 8172749
[TBL] [Abstract][Full Text] [Related]
17. Safety and pharmacokinetics of ioversol in healthy volunteers.
Wilkins RA; Whittington JR; Brigden GS; Lahiri A; Heber ME; Hughes LO
Invest Radiol; 1989 Oct; 24(10):781-8. PubMed ID: 2793391
[TBL] [Abstract][Full Text] [Related]
18. Effect of iopentol on renal function and its use for calculation of glomerular filtration rate in children.
Stake G; Monclair T; Berg KJ; Rootwelt K; Brekke O
Acta Radiol; 1995 Jan; 36(1):64-8. PubMed ID: 7833171
[TBL] [Abstract][Full Text] [Related]
19. The influence of non-ionic contrast media on the endothelium of small arteries. A comparison of metrizamide, iohexol and iopentol.
Wieslander JB; Stjernquist U
Acta Radiol Suppl; 1987; 370():73-7. PubMed ID: 2980317
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of iohexol, a new nonionic radiocontrast agent, in humans.
Edelson J; Shaw D; Palace G
J Pharm Sci; 1984 Jul; 73(7):993-5. PubMed ID: 6470969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
